{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:32:26Z","timestamp":1765827146292},"reference-count":21,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2014,3,19]]},"published-print":{"date-parts":[[2014,4]]},"abstract":"Introduction<\/jats:title>Interventions to improve adherence to treatment for latent tuberculosis infection (LTBI) are necessary to improve treatment completion rates and optimise tuberculosis (TB) control efforts. The high prevalence of cell phone use presents opportunities to develop innovative ways to engage patients in care. A randomised controlled trial (RCT), WelTel Kenya1, demonstrated that weekly text messages improved antiretroviral adherence and clinical outcomes among patients initiating HIV treatment. The aim of this study is to determine whether the WelTel intervention can improve treatment completion among patients with LTBI and to evaluate the intervention's cost-effectiveness.<\/jats:p><\/jats:sec>Methods and analysis<\/jats:title>This open, two-site, parallel RCT (WelTel LTBI) will be conducted at TB clinics in Vancouver and New Westminster, British Columbia, Canada. Over 2\u2005years, we aim to recruit 350 individuals initiating a 9-month isoniazid regimen. Participants will be randomly allocated to an intervention or control (standard care) arm in a 1:1 ratio. Intervention arm participants will receive a weekly text-message \u2018check-in\u2019 to which they will be asked to respond within 48\u2005h. A TB clinician will follow-up instances of non-response and problems that are identified. Participants will be followed until treatment completion (up to 12\u2005months) or discontinuation. The primary outcome is self-reported treatment completion (taking \u226580% of doses within 12\u2005months). Secondary outcomes include daily adherence (percentage of days participants used medication as prescribed) and time to treatment completion. Patient satisfaction with the intervention will be evaluated, and the intervention's cost-effectiveness will be analysed through decision-analytic modelling.<\/jats:p><\/jats:sec>Ethics and dissemination<\/jats:title>Ethical approval has been obtained from the University of British Columbia. This trial will test the efficacy and cost-effectiveness of the WelTel intervention to improve treatment completion among patients with LTBI. Trial results and economic evaluation will help inform policy and practice on the use of WelTel in this population.<\/jats:p><\/jats:sec>Trial registration number<\/jats:title>ClinicalTrials.govNCT01549457<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2013-004362","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T03:01:34Z","timestamp":1397098894000},"page":"e004362","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["The effect of weekly text-message communication on treatment completion among patients with latent tuberculosis infection: study protocol for a randomised controlled trial (WelTel LTBI)"],"prefix":"10.1136","volume":"4","clinical-trial-number":[{"clinical-trial-number":"nct01549457","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mia L","family":"van der Kop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina","family":"Memetovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anik","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawziah","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Sadatsafavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hajek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Smillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darlene","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T","family":"Lester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"2024051511382159000_4.4.e004362.1","unstructured":"World Health Organization. Global tuberculosis report. Geneva: World Health Organization, 2012."},{"key":"2024051511382159000_4.4.e004362.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200702-187OC"},{"key":"2024051511382159000_4.4.e004362.3","first-page":"599","article-title":"Tuberculosis among immigrants: interval from arrival in Canada to diagnosis. A 5-year study in southern Alberta","volume":"158","author":"Cowie","year":"1998","journal-title":"CMAJ"},{"key":"2024051511382159000_4.4.e004362.4","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"Comstock","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024051511382159000_4.4.e004362.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030438"},{"key":"2024051511382159000_4.4.e004362.6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0394"},{"key":"2024051511382159000_4.4.e004362.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp021045"},{"key":"2024051511382159000_4.4.e004362.8","first-page":"1235","article-title":"Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada","volume":"12","author":"Hirsch-Moverman","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024051511382159000_4.4.e004362.9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.4.1296"},{"key":"2024051511382159000_4.4.e004362.10","first-page":"775","article-title":"A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection","volume":"10","author":"Nyamathi","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024051511382159000_4.4.e004362.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61997-6"},{"key":"2024051511382159000_4.4.e004362.12","first-page":"7","article-title":"Use of the WelTel mobile health intervention at a tuberculosis clinic in British Columbia: a pilot study","volume":"2","author":"van der Kop","year":"2013","journal-title":"JMTM"},{"key":"2024051511382159000_4.4.e004362.13","unstructured":"Bridges.org. On cue compliance service pilot: testing the use of SMS reminders in the treatment of tuberculosis in Cape Town, South Africa. Cape Town, 2005."},{"issue":"(4S)","key":"2024051511382159000_4.4.e004362.14","first-page":"23","article-title":"TextTB: a parallel design randomized controlled pilot study to evaluate acceptance and feasibility of a patient-driven mobile phone based intervention","volume":"1","author":"Iribarren","year":"2012","journal-title":"JMTM"},{"key":"2024051511382159000_4.4.e004362.15","unstructured":"BC Centre for Disease Control. TB in British Columbia: annual surveillance report 2011. Vancouver: Provincial Health Services Authority, 2013."},{"key":"2024051511382159000_4.4.e004362.16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/1471-2334-13-566","article-title":"Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review","volume":"13","author":"Nglazi","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2024051511382159000_4.4.e004362.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)06532-X"},{"key":"2024051511382159000_4.4.e004362.18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-10-200811180-00003"},{"key":"2024051511382159000_4.4.e004362.19","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199603000-00003"},{"key":"2024051511382159000_4.4.e004362.20","unstructured":"Public Health Agency of Canada. Canadian tuberculosis standards. 7th edn. Ottawa: Public Health Agency of Canada, 2013."},{"key":"2024051511382159000_4.4.e004362.21","unstructured":"Quorus Consulting Group. 2012 cell phone consumer attitudes study. Ottawa: Quorus Consulting Group Ltd, 2012."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2013-004362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T18:41:24Z","timestamp":1715798484000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2013-004362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1136\/bmjopen-2013-004362"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2013-004362","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}